Skip to main content
logo
Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
71.36
+0.45 (0.63%)
Sep 1, 2026, 10:54 AM EDT - Market open

Cytokinetics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9,9217,7695,5518,1864,3363,823
Market Cap Growth
134.67%39.94%-32.19%88.80%13.41%159.96%
Enterprise Value
10,1798,1565,4488,3964,2103,612
Last Close Price
70.9163.5447.0483.4945.8245.58

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
143.2888.24300.501087.1845.8454.29
PB Ratio
--11.78-41.01-21.19-40.1815.68
P/TBV Ratio
-----15.68

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
147.1092.65294.901115.0344.5051.29

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-8.21-2.18-6.82-1.96-6.951.11
Net Debt / Equity Ratio
-1.49-0.841.13-0.360.30-0.83
Net Debt / EBITDA Ratio
-0.37-0.920.29-0.290.101.10
Net Debt / FCF Ratio
-0.45-1.040.38-0.340.101.05
Asset Turnover
0.040.060.020.010.100.10
Quick Ratio
6.564.456.086.009.257.35
Current Ratio
6.664.536.176.129.407.45
Return on Equity (ROE)
-----572.15%-120.54%
Return on Assets (ROA)
-28.09%-27.08%-30.11%-33.73%-21.83%-16.94%
Return on Capital Employed (ROCE)
-40.60%-50.10%-43.90%-68.80%-34.90%-24.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.22%-10.10%-10.62%-6.43%-8.97%-5.63%
FCF Yield
-5.99%-6.88%-7.20%-5.08%-7.17%-5.01%
Buyback Yield / Dilution
-5.07%-7.26%-16.01%-7.46%-16.83%-19.16%
SEC Filings: 10-K · 10-Q